Literature DB >> 35795833

Improvement of atopic dermatitis and alopecia universalis with dupilumab.

Lama Alotaibi1, Abdulrahman Alfawzan2, Raghad Alharthi2, Afaf Al Sheikh3.   

Abstract

Dupilumab is an interleukin-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis and alopecia totalis after dupilumab treatment for AD. We present one of reported cases that showed improvement of underlying alopecia universalis treated with dupilumab. ©Copyright: the Author(s).

Entities:  

Keywords:  Alopecia Areata; Alopecia Universalis; Atopic Dermatitis; Dupilumab

Year:  2021        PMID： 35795833      PMCID： PMC9251532          DOI： 10.4081/dr.2022.9359

Source DB:  PubMed          Journal:  Dermatol Reports        ISSN： 2036-7392


  9 in total

1.  Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing.

Authors:  Mayte Suárez-Fariñas; Benjamin Ungar; Shinji Noda; Anjali Shroff; Yasaman Mansouri; Judilyn Fuentes-Duculan; Annette Czernik; Xiuzhong Zheng; Yeriel D Estrada; Hui Xu; Xiangyu Peng; Avner Shemer; James G Krueger; Mark G Lebwohl; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-08-24       Impact factor: 10.793

2.  Flow cytometric analysis of IL-4, IL-13 and IFN-gamma expression in peripheral blood mononuclear cells and detection of circulating IL-13 in patients with atopic dermatitis provide evidence for the involvement of type 2 cytokines in the disease.

Authors:  Kyoko Kaminishi; Yoshinao Soma; Yoko Kawa; Masako Mizoguchi
Journal:  J Dermatol Sci       Date:  2002-05       Impact factor: 4.563

3.  Alopecia areata development in atopic dermatitis patients treated with dupilumab.

Authors:  S Ständer; Y Trense; D Thaçi; R J Ludwig
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05-19       Impact factor: 6.166

Review 4.  Dupilumab for treatment of atopic dermatitis.

Authors:  Marlene Seegräber; Jerome Srour; Alexandra Walter; Macarena Knop; Andreas Wollenberg
Journal:  Expert Rev Clin Pharmacol       Date:  2018-03-20       Impact factor: 5.045

Review 5.  Viral infections in atopic dermatitis: pathogenic aspects and clinical management.

Authors:  Andreas Wollenberg; Stefanie Wetzel; Walter H C Burgdorf; Jürgen Haas
Journal:  J Allergy Clin Immunol       Date:  2003-10       Impact factor: 10.793

6.  Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci.

Authors:  Regina C Betz; Lynn Petukhova; Stephan Ripke; Hailiang Huang; Androniki Menelaou; Silke Redler; Tim Becker; Stefanie Heilmann; Tarek Yamany; Madeliene Duvic; Maria Hordinsky; David Norris; Vera H Price; Julian Mackay-Wiggan; Annemieke de Jong; Gina M DeStefano; Susanne Moebus; Markus Böhm; Ulrike Blume-Peytavi; Hans Wolff; Gerhard Lutz; Roland Kruse; Li Bian; Christopher I Amos; Annette Lee; Peter K Gregersen; Bettina Blaumeiser; David Altshuler; Raphael Clynes; Paul I W de Bakker; Markus M Nöthen; Mark J Daly; Angela M Christiano
Journal:  Nat Commun       Date:  2015-01-22       Impact factor: 14.919

7.  Cytokine modulation of atopic dermatitis filaggrin skin expression.

Authors:  Michael D Howell; Byung Eui Kim; Peisong Gao; Audrey V Grant; Mark Boguniewicz; Anna DeBenedetto; Lynda Schneider; Lisa A Beck; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2009-09       Impact factor: 10.793
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.